ALS2 antibody (AA 1007-1056)
-
- Target See all ALS2 Antibodies
- ALS2 (Amyotrophic Lateral Sclerosis 2 (Juvenile) (ALS2))
-
Binding Specificity
- AA 1007-1056
- Reactivity
- Human, Mouse, Rat, Cow, Dog, Guinea Pig, Horse, Bat, Chicken, Monkey
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This ALS2 antibody is un-conjugated
-
Application
- Western Blotting (WB)
- Specificity
- Human ALS2
- Predicted Reactivity
- Percent identity by BLAST analysis: Human, Mouse, Rat, Dog, Bovine, Horse, Chicken (100%) Rabbit (92%) Guinea pig (85%).
- Purification
- Immunoaffinity purified
- Immunogen
-
Synthetic peptide located between aa1007-1056 of human ALS2 (Q96Q42, NP_065970). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Gibbon, Galago, Marmoset, Mouse, Rat, Elephant, Dog, Bovine, Bat, Horse, Turkey, Zebra finch, Chicken (100%), Rabbit, Opossum (92%), Guinea pig (85%).
Type of Immunogen: Synthetic peptide - Top Product
- Discover our top product ALS2 Primary Antibody
-
-
- Application Notes
-
Approved: WB (0.2 - 1 μg/mL)
Usage: Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as secondary antibody. - Comment
-
Target Species of Antibody: Human
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Distilled water
- Concentration
- Lot specific
- Buffer
- Lyophilized from PBS with 2 % sucrose
- Handling Advice
- Avoid repeat freeze-thaw cycles.
- Storage
- 4 °C,-20 °C
- Storage Comment
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
- Target
- ALS2 (Amyotrophic Lateral Sclerosis 2 (Juvenile) (ALS2))
- Alternative Name
- ALS2 / Alsin (ALS2 Products)
- Background
-
Name/Gene ID: ALS2
Synonyms: ALS2, ALS2CR6, ALSJ, IAHSP, Alsin, PLSJ, KIAA1563 - Gene ID
- 57679
- NCBI Accession
- NP_065970
- UniProt
- Q96Q42
- Pathways
- Skeletal Muscle Fiber Development
-